Biotech IPO market analysis mentions JOBS Act and testing‑the‑waters meetings

Biotech IPO market analysis mentions JOBS Act and testing‑the‑waters meetings The passage only discusses market trends, the JOBS Act, and generic investor behavior. It contains no specific individuals, transactions, dates, or allegations linking powerful actors to misconduct, offering no actionable investigative lead. Key insights: Mentions the JOBS Act as a factor in expanding biotech IPO activity; References “testing the waters” meetings as a tool for fund managers; Provides aggregate data on IPO counts and capital raised (2004‑2014)